Bosentan therapy for patients with severe Raynaud’s phenomenon in systemic sclerosis

Saved in:
Bibliographic Details
Published inAnnals of the rheumatic diseases Vol. 66; no. 10; pp. 1398 - 1399
Main Authors Hettema, M E, Zhang, D, Bootsma, H, Kallenberg, C G M
Format Journal Article
LanguageEnglish
Published England BMJ Publishing Group Ltd and European League Against Rheumatism 01.10.2007
BMJ Publishing Group LTD
BMJ Group
Subjects
Adult
Aged
Antihypertensive Agents - therapeutic use
bosentan
Female
Humans
Letters
Male
Middle Aged
Raynaud Disease - drug therapy
Raynaud’s phenomenon
Scleroderma, Systemic - complications
Sulfonamides - therapeutic use
systemic sclerosis
Treatment Outcome
Online AccessGet full text

Cover

More Information
Bibliography:ark:/67375/NVC-LGQ6PK4N-Z
istex:403F36E2DC09DEEB5105BDD6CE670BE80564D47D
local:annrheumdis;66/10/1398
ArticleID:ar73684
PMID:17881663
href:annrheumdis-66-1398.pdf
SourceType-Other Sources-1
content type line 63
ObjectType-Correspondence-1
ISSN:0003-4967
1468-2060
DOI:10.1136/ard.2007.073684